American journal of hematology
Chimeric Antigen Receptor T-Cells (CAR T-Cells) in Hematological Malignancies: A Systematic Review and Meta-Analysis of Proportions From Clinical Trials.
Charalampos Filippatos, Ioanna Kanteli, Dafni Georgia Pasipoularidou, Maria Gavriatopoulou, Anastasios Tentolouris, Panagiotis Malandrakis, Theodoros N Sergentanis, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos
Published: 202610.1002/ajh.70201
Abstract
This meta-analysis examined the safety and efficacy of CAR T-cell therapy in 3281 patients with hematological malignancies enrolled in phase 1/2, 2 and 3 clinical trials, published until July 23, 2025 according to the PRISMA guidelines. All trials in…
Preview only. Read the full abstract at the source